Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets

Biofrontera Inc. (BFRIW)

NCM

$0.040.00 (0.00%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
P/E (TTM)
EPS
$-1.30
Div Yield
52W Range
$0.03–$0.04
Beta
0.82

Company overview

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Peers in industry

Biofrontera Inc. has no peer companies in this window.

Recent press releases

Biofrontera Inc. has not issued a press release in this window.

SEC filings

All filings →

Biofrontera Inc. has not filed an SEC document in this window.

Biofrontera Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
915,210 sh-12.5%
1,140,764 sh0.0%
113,951 sh0.0%
32,820 sh● NEW
13,476 sh-35.2%
18,867 sh+4.8%
10,100 sh● NEW

People at Biofrontera Inc.

All people →

No officers or directors have been indexed for Biofrontera Inc..

Quarterly financials

Full financials →
Revenue trend
03/25
$8.6M
NI -$4.2M
06/25
$9.0M
NI -$5.3M
09/25
$7.0M
NI -$6.6M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.62
Prior: $-0.57
Revenue sparkline
Biofrontera Inc. (BFRIW) Stock Quote, Press... | Cayman Journal | Cayman Journal